User profiles for J. Félix-Cardoso
 | Jorge Félix CardosoOther name: J Félix-Cardoso Researcher, Faculty of Medicine of the University of Porto Verified email at med.up.pt Cited by 47 |
Excess mortality during COVID-19 in five European countries and a critique of mortality data analysis
J Felix-Cardoso, H Vasconcelos, P Pereira Rodrigues… - MedRxiv, 2020 - medrxiv.org
INTRODUCTION The COVID-19 pandemic is an ongoing event disrupting lives, health
systems, and economies worldwide. Clear data about the pandemic’s impact is lacking, namely …
systems, and economies worldwide. Clear data about the pandemic’s impact is lacking, namely …
A Synthetic Conjugate Polysaccharide Vaccine Against Haemophilus influenzae Type b
V Verez-Bencomo, V Fernandez-Santana, E Hardy… - Science, 2004 - science.org
Glycoconjugate vaccines provide effective prophylaxis against bacterial infections. To date,
however, no commercial vaccine has been available in which the key carbohydrate antigens …
however, no commercial vaccine has been available in which the key carbohydrate antigens …
[HTML][HTML] Uso do ácido poli-L-láctico como restaurador de volume facial
RMSF Silva, GF Cardoso - Revista Brasileira de Cirurgia Plástica, 2013 - SciELO Brasil
INTRODUÇÃO: O ácido poli-L-láctico é usado na Europa, para fins cosméticos, desde 1999,
e nos Estados Unidos, para tratamento de lipoatrofia pelo HIV, desde 2004. Este trabalho …
e nos Estados Unidos, para tratamento de lipoatrofia pelo HIV, desde 2004. Este trabalho …
Safety and immunogenicity of anti-SARS CoV-2 vaccine SOBERANA 02 in homologous or heterologous scheme: Open label phase I and phase IIa clinical trials
…, E Galano-Frutos, J Rodríguez-Alvarez… - Vaccine, 2022 - Elsevier
Background SOBERANA 02 is a COVID-19 vaccine based on SARS-CoV-2 recombinant
RBD conjugated to tetanus toxoid (TT). SOBERANA Plus antigen is dimeric-RBD. Here we …
RBD conjugated to tetanus toxoid (TT). SOBERANA Plus antigen is dimeric-RBD. Here we …
[PDF][PDF] Safety and immunogenicity of anti-SARS-CoV-2 heterologous scheme with SOBERANA 02 and SOBERANA Plus vaccines: Phase IIb clinical trial in adults
…, J Lora-García, M Medina-Nápoles, J Espi-Ávila… - Med, 2022 - cell.com
Background SOBERANA 02 has been evaluated in phase I and IIa studies comparing
homologous versus heterologous schedule (this one, including SOBERANA Plus). Here, we …
homologous versus heterologous schedule (this one, including SOBERANA Plus). Here, we …
SARS-CoV-2 RBD-Tetanus toxoid conjugate vaccine induces a strong neutralizing immunity in preclinical studies
…, H Gonzalez, M Farinas, J Enriquez… - ACS Chemical …, 2021 - ACS Publications
Controlling the global COVID-19 pandemic depends, among other measures, on developing
preventive vaccines at an unprecedented pace. Vaccines approved for use and those in …
preventive vaccines at an unprecedented pace. Vaccines approved for use and those in …
COVID-19 e Segurança Sanitária: O que muda?
A Opitz, C Mateus, C Sakellarides, F George, H Martins… - IDN Brief, 27, 2020 - JSTOR
The current COVID-19 pandemic simultaneously challenges states and societies on every
continent. The pandemic does not only affect health systems. The complex effects of COVID-…
continent. The pandemic does not only affect health systems. The complex effects of COVID-…
Antigenicity and Immunogenicity of a Synthetic Oligosaccharide-Protein Conjugate Vaccine against Haemophilus influenzae Type b
…, MC Rodríguez, I Figueroa, J Chang… - Infection and …, 2004 - Am Soc Microbiol
Polysaccharide-protein conjugates as vaccines have proven to be very effective in preventing
Haemophilus influenzae type b infections in industrialized countries. However, cost-…
Haemophilus influenzae type b infections in industrialized countries. However, cost-…
Relevance of O-acetyl and phosphoglycerol groups for the antigenicity of Streptococcus pneumoniae serotype 18C capsular polysaccharide
J Chang, Y Serrano, R Garrido, LM Rodríguez… - Vaccine, 2012 - Elsevier
Capsular polysaccharides are important virulence factors of Streptococcus pneumoniae.
The polysaccharide has been used as a component of vaccines against pneumococcal …
The polysaccharide has been used as a component of vaccines against pneumococcal …
Quantitative proton nuclear magnetic resonance evaluation and total assignment of the capsular polysaccharide Neisseria meningitidis serogroup X
R Garrido, A Puyada, A Fernández, M González… - … of pharmaceutical and …, 2012 - Elsevier
… The edited HSQC ( 1 H– 13 C) delay for single quantum evolution was optimized for 1 J H–…
( 1 H– 31 P) delay for developing the heteronuclear correlation was optimized for 3 J H–P …
( 1 H– 31 P) delay for developing the heteronuclear correlation was optimized for 3 J H–P …